INDIAN BENCHMARKS at record highs as traders rolled over their positions in the futures & options (F&O) segment from the near-month March 2014 series to April 2014 series.
Further, Lupin has acquired 100 % equity stake in Mexico-based Laboratorios Grin subject to certain closing conditions. The acquisition marks Lupin’s foray into the high growth Mexican and the larger Latin American pharmaceuticals market. Dr Reddy’s Laboratories Ltd has launched Amlodipine Besylate and Atorvastatin Calcium tablets in the US market.
The crucial resistance for Nifty is now seen at 6670 and above this 6710. Support for the immediate term is now placed at 6540 and next support will be 6500.
The Sensex is up 132.43 points at 26051.38 and the Nifty is up 32.05 points at 7771.60 till now.
ReplyDeleteNifty future tips provider India